Metraipolis › archive › dc_74df83fa7cb2

Case Report: Treatment of refractory lung disease in systemic juvenile idiopathic arthritis with cyclophosphamide and rituximab combination therapy — Europe PMC PMID:42158853

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42158853
DOI: 10.3389/fimmu.2026.1798455
License (as archived): solo-consultazione
Archived: 2026-11-02T18:14:34.515Z
SHA-256 of the archived text: a904492f882297a03522ef8e8ff57df7fd5419e1054cf6579064e69954b25a61
Stable URL of this page: https://metraipolis.com/documento/dc_74df83fa7cb2

How to cite

Case Report: Treatment of refractory lung disease in systemic juvenile idiopathic arthritis with cyclophosphamide and rituximab combination therapy — Europe PMC PMID:42158853 — Europe PMC (en), https://europepmc.org/article/MED/42158853 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_74df83fa7cb2 (Metraipolis archive dc_74df83fa7cb2, sha256 a904492f882297a03522ef8e8ff57df7fd5419e1054cf6579064e69954b25a61)

BibTeX

@misc{dc74df83fa7cb2,
  title = {Case Report: Treatment of refractory lung disease in systemic juvenile idiopathic arthritis with cyclophosphamide and rituximab combination therapy — Europe PMC PMID:42158853},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42158853},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_74df83fa7cb2; sha256 a904492f882297a03522ef8e8ff57df7fd5419e1054cf6579064e69954b25a61},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42158853. Agents can read the archived copy with the MCP tool read_document.